NCT05356351
- Conditions
- Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
- Locations
-
Not specified
Clinical trial condition
Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
Explore clinical trials studying Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies